Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-744
Closed -$497K 110
2022
Q1
$497K Buy
744
+56
+8% +$37.5K 0.21% 76
2021
Q4
$548K Buy
688
+30
+5% +$23.8K 0.23% 71
2021
Q3
$490K Sell
658
-4
-0.6% -$3.14K 0.23% 72
2021
Q2
$457K Buy
662
+30
+5% +$19.8K 0.22% 72
2021
Q1
$390K Sell
632
-4
-0.6% -$2.22K 0.21% 75
2020
Q4
$310K Sell
636
-1
-0.2% -$421 0.19% 75
2020
Q3
$235K Buy
637
+1
+0.2% +$374 0.16% 78
2020
Q2
$234K Buy
+636
New +$200K 0.17% 75

Other funds holding ASML

Shilanski & Associates's ASML Position: Q2 2022 in Review

Shilanski & Associates sold out of ASML (ASML) in Q2 2022, closing a stake of 744 shares — an estimated $497K sold.

Shilanski & Associates first reported a position in ASML in Q2 2020 and held it in 8 quarters. The position peaked at $548K in Q4 2021. 921 funds tracked by Wall St. Rank hold ASML as of Q2 2022.

  • Shilanski & Associates reported no remaining ASML position as of Q2 2022 after selling out during the quarter.
  • Shilanski & Associates sold 744 ASML shares in Q2 2022, an estimated $497K.
  • Shilanski & Associates first reported a position in ASML in Q2 2020 and held it in 8 quarters.
  • Shilanski & Associates's ASML position peaked at $548K in Q4 2021.
  • 921 funds tracked by Wall St. Rank held ASML as of Q2 2022.

Based on Shilanski & Associates's 13F filing for Q2 2022, filed 2 Aug 2022.